Evidence map›Paper›PMID 35026304›Full record

ArticleJournal of virological methods2022

Detection of a characteristic melting profile of a SARS-CoV-2 Kappa variant in Italy using the SARS-CoV-2 Variants ELITe MGB® Kit.

Margherita Scapaticci, Andrea Bartolini, Francesca Vitone, Vincenzo Cerreta, Monica Vignoli, Elena Gnudi, Alessandra Frazzoni, Barbara Sitta, Silvia Capitani, Annamaria Lopriore and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virological methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Margherita ScapaticciLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Andrea BartoliniLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy. Electronic address: andrea.bartolini@ausl.bologna.it.
Francesca VitoneLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Vincenzo CerretaLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Monica VignoliLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Elena GnudiLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Alessandra FrazzoniLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Barbara SittaLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Silvia CapitaniLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Annamaria LoprioreLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Mariapina DonadioLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Stefania ChiarastellaLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Marina BioliLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
Rita ManciniLUM, AUSL Bologna, Largo Nigrisoli 2, 40133, Bologna, Italy.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough more than a year has passed since the start of the pandemic, SARS-CoV-2 infection still represents a major challenge for public health all over the world due to viral genome capability of gaining rapid mutations. Whole-genome sequencing (WGS) is the gold standard for variant identification, but it is time consuming and relatively expensive. For this reason, assays targeting multiple regions of the SARS-CoV-2 genome may be useful for a rapid traceability of either known or new variants, anyway, not all the manufacturers are able to sustain the rapid development of variants.

objectiveWe tested forty nasopharyngeal swabs, resulted positive for the presence of SARS-CoV-2 RNA at low cycle threshold (CT < 25), with SARS-CoV-2 Variants ELITe MGB® Kit, which was designed to identify Nigerian variant, possible UK variant and South African or Brazilian variant.

resultsDuring the analysis, we noted an atypical melting curve, different from the other variants recognizable by the kit. The subsequent WGS reported this variant as Kappa, so we assess the possibility of "suspecting" the presence of a Kappa variant using SARS-CoV-2 Variants ELITe MGB® Kit.

conclusionsRapid variant screening followed by WGS offers the opportunity to study mutation dynamics and quickly identify possible variants of interest (VOI) and/or variants of concern (VOC), which is crucial in virus spreading control. Furthermore, an accurate analysis of the melting peak could be useful to suspect the presence of new variants.

Indexed as

COVID-19SARS-CoV-2COVID-19 Nucleic Acid TestingHumansItalyMutationRNA, ViralWhole Genome SequencingRNA, ViralKappa variantMelting curve analysisSARS-CoV-2

Identifiers

PMID35026304
PMCPMC8758410
OpenAlexW4206202510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.